Product Program year 2025 Source: CMS Open Payments

DXH 900 Hematology System

Device Devices

PDI 15099590701574

Open in the dashboard

General payments

$132,392

349 payments

Research payments

$2,478,343

73 payments

Through program year 2025, $132,392 in general payments and $2,478,343 in research payments were reported against DXH 900 Hematology System (Devices).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 General $52,952 74
2025 Research $591,981 35
2024 General $12,329 79
2024 Research $567,878 10
2023 General $9,446 130
2023 Research $575,148 13
2022 General $57,665 66
2022 Research $743,336 15

Breakdown

Who paid General payments · program years 2022–2025
  1. Beckman Coulter, Inc. $132,392 349 payments
Top recipients General payments · program year 2025
  1. David Shulkin Internal Medicine · Morristown, NJ $50,000 94% · 10 payments
  2. Richard Hamilton Emergency Medicine · Philadelphia, PA $1,425 3% · 1 payment
  3. Doctor Goldstein Molecular Genetic Pathology · Bronx, NY $193 <1% · 8 payments
  4. Adam Cole Clinical Pathology · Bronx, NY $115 <1% · 5 payments
  5. Muhammad Cheema Anatomic Pathology & Clinical Pathology · Bellerose, NY $61 <1% · 2 payments

The top 5 of 50 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Internal Medicine $50,029 94% · 2 practitioners
  2. Emergency Medicine $1,547 3% · 5 practitioners
  3. Anatomic Pathology & Clinical Pathology Pathology $739 1% · 28 practitioners
  4. Molecular Genetic Pathology Pathology $193 <1% · 1 practitioner
  5. Clinical Pathology Pathology $135 <1% · 2 practitioners

The top 5 of 14 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $51,482 97% · 3 recipients
  2. New York $527 <1% · 7 recipients
  3. California $338 <1% · 14 recipients
  4. Texas $181 <1% · 8 recipients
  5. Michigan $147 <1% · 6 recipients

The top 5 of 13 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

349 general · 73 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record